Ascendis Pharma AS (ASND)
124.28
-1.75
(-1.39%)
USD |
NASDAQ |
Nov 14, 16:00
114.90
-9.38
(-7.55%)
After-Hours: 07:22
Ascendis Pharma Total Return Level: 124.28 for Nov. 14, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 14, 2024 | 124.28 |
November 13, 2024 | 126.03 |
November 12, 2024 | 127.67 |
November 11, 2024 | 128.40 |
November 08, 2024 | 124.33 |
November 07, 2024 | 126.55 |
November 06, 2024 | 129.36 |
November 05, 2024 | 128.13 |
November 04, 2024 | 125.77 |
November 01, 2024 | 125.28 |
October 31, 2024 | 122.82 |
October 30, 2024 | 122.80 |
October 29, 2024 | 126.77 |
October 28, 2024 | 129.44 |
October 25, 2024 | 130.32 |
October 24, 2024 | 129.81 |
October 23, 2024 | 127.69 |
October 22, 2024 | 129.07 |
October 21, 2024 | 128.66 |
October 18, 2024 | 129.90 |
October 17, 2024 | 126.66 |
October 16, 2024 | 130.31 |
October 15, 2024 | 127.30 |
October 14, 2024 | 128.46 |
October 11, 2024 | 128.87 |
Date | Value |
---|---|
October 10, 2024 | 130.33 |
October 09, 2024 | 129.30 |
October 08, 2024 | 132.05 |
October 07, 2024 | 139.14 |
October 04, 2024 | 142.67 |
October 03, 2024 | 140.95 |
October 02, 2024 | 146.29 |
October 01, 2024 | 146.60 |
September 30, 2024 | 149.31 |
September 27, 2024 | 144.62 |
September 26, 2024 | 147.36 |
September 25, 2024 | 146.27 |
September 24, 2024 | 144.89 |
September 23, 2024 | 146.60 |
September 20, 2024 | 151.26 |
September 19, 2024 | 153.43 |
September 18, 2024 | 148.88 |
September 17, 2024 | 146.59 |
September 16, 2024 | 139.57 |
September 13, 2024 | 119.22 |
September 12, 2024 | 113.81 |
September 11, 2024 | 112.93 |
September 10, 2024 | 114.76 |
September 09, 2024 | 116.84 |
September 06, 2024 | 119.15 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
69.96
Minimum
Apr 28 2023
182.76
Maximum
Dec 14 2020
125.12
Average
127.18
Median
Total Return Level Benchmarks
Novo Nordisk AS | 183.95 |
Evaxion Biotech AS | 1.68 |
Biodexa Pharmaceuticals PLC | 4.86 |
NuCana PLC | 1.55 |
Genfit SA | 4.535 |